Skip to main content

Table 2 Distribution of breast cancer subtypes in different subgroups

From: A signature of epithelial-mesenchymal plasticity and stromal activation in primary tumor modulates late recurrence in breast cancer independent of disease subtype

Subgroup

Subtype

N

Percentage (%)

Fisher’s exact test (Pvalue)

Odds ratio (OR)

95% confidence interval (95% CI)

G1

Luminal A

85

96.5

4.90E-11

14.3244

4.4797 - 45.8043

 

Luminal B

1

1.1

0.0143

0.1324

0.0181 - 0.9693

 

HER2 type

1

1.1

0.0329

0.1574

0.0214 - 1.1559

 

TNBC

1

1.1

1.12E-06

0.0497

0.0069 - 0.3602

G2

Luminal A

192

62.5

3.88E-04

0.5614

0.4105 - 0.7678

 

Luminal B

30

9.8

0.0315

1.8715

1.0778 - 3.2496

 

HER2 type

22

7.2

0.3592

1.3339

0.7378 - 2.4115

 

TNBC

63

20.5

0.0234

1.5571

1.0631 - 2.2806

G3

Luminal A

144

63.7

0.0195

0.6664

0.4788 - 0.9275

 

Luminal B

16

7.1

0.6541

0.844

0.461 - 1.5453

 

HER2 type

17

7.5

0.6311

1.1713

0.6317 - 2.1719

 

TNBC

49

21.7

0.1185

1.3737

0.9225 - 2.0456

G4

Luminal A

113

79

0.0085

1.7894

1.1567 - 2.7682

 

Luminal B

8

5.6

0.4771

0.7237

0.3342 - 1.5673

 

HER2 type

7

4.9

0.5674

0.7476

0.3278 - 1.705

 

TNBC

15

10.5

0.0255

0.5268

0.2972 - 0.9338

  1. CI: confidence interval; HER2: human epidermal growth factor receptor 2; TNBC: triple-negative breast cancer.